For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Rabbit monoclonal [EPR9934(B)] to MYL1
, Flow Cytmore detailsUnsuitable for:
ICC/IF,IHC-P or IP
Mouse, Rat, Human
Synthetic peptide (the amino acid sequence is considered to be commercially sensitive)
- Human skeletal muscle, HT1080 and Saos2 lysates; HT1080 cells
This product is a recombinant rabbit monoclonal antibody.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
Shipped at 4°C. Store at -20ºC.
Preservative: 0.01% Sodium azide
Constituents: 50% Glycerol, 0.05% BSA
Tissue culture supernatant
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/1000 - 1/10000. Predicted molecular weight: 21 kDa.
||1/10 - 1/100. ab172730-Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
Is unsuitable for ICC/IF,IHC-P or IP.
Regulatory light chain of myosin. Does not bind calcium.
Contains 3 EF-hand domains.
Isoform MLC3 is acetylated at position 2.
Information by UniProt
- A1 catalytic antibody
- Alkali myosin light chain 1 antibody
- MLC1/MLC3 antibody
Western blot - Anti-MYL1 antibody [ EPR9934(B)] (ab151749)
All lanes : Anti-MYL1 antibody [EPR9934(B)] (ab151749) at 1/1000 dilution
Lane 1 : Human skeletal
Lane 2 : HT1080 lysate
Lane 3 : Saos2 lysate
Lysates/proteins at 10 µg per lane.
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size : 21 kDa
Flow Cytometry - Anti-MYL1 antibody [ EPR9934(B)] (ab151749)
Flow cytometric analysis of permeabilized HT1080 cells labeling MYL1 with ab151749 at 1/10 dilution (red), compared with a negative control rabbit IgG (green).
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"